Clinical Trial: Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized, Double Blind, Placebo Controlled, Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
Brief Summary: To evaluate the efficacy and safety of KLS-0611 compared to placebo in patients with dry eye syndromes.
Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.
Current Primary Outcome: Corneal-conjunctival staining [ Time Frame: 4 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Kissei Pharmaceutical Co., Ltd.
Dates:
Date Received: July 22, 2008
Date Started:
Date Completion:
Last Updated: March 16, 2009
Last Verified: March 2009